Back to MW MARSHALL WACE, LLP

TMCITMCI
Showing 8 of 18 quarters

Position history for MWMARSHALL WACE, LLP's holdings in TREACE MED CONCEPTS INC

Yes. Marshall Wace holds 1,328,592 shares of TMCI (Treace Med Concepts), worth $5.3M, as of its Q2 2026 13F filing. It increased the position from 264,933 shares in Q1 2026. Marshall Wace has held TMCI since Q1 2026, across 2 quarterly 13F filings.

Current Value

$5.3M

Current Shares

1.3M

Total Value Change

+$2.8M

Total Shares Change

+901,862

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+401.5%
$5.3M0.0%$3.98
44
2026-Q1
New
264,933
-
$355,0100.0%$1.57
33
2025-Q4
Exited
0
-100.0%
$00.0%$2.48
0
2025-Q3
Decreased
11,758
-91.3%
$78,8960.0%$6.72
0
2025-Q2
Increased
135,877
+256.2%
$798,9560.0%$5.75
40
2025-Q1
Decreased
38,148
-57.1%
$320,0610.0%$8.45
0
2024-Q4
Decreased
88,910
-79.2%
$661,4920.0%$6.88
0
2024-Q3
Decreased
426,730
-7.8%
$2.5M0.0%$5.77
0

Other major holders of TMCI: CIBC Private Wealth Group LLC, ALLIANCEBERNSTEIN L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used